LEADER 02908nas 2200937-a 450 001 996204134003316 005 20221208213020.0 011 $a1279-8509 035 $a(DE-599)ZDB1499933-X 035 $a(OCoLC)42964399 035 $a(CKB)954925614016 035 $a(CONSER)--2007233416 035 $a(EXLCZ)99954925614016 100 $a19991209b19962000 s-- - 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aHematology and cell therapy 210 $aParis $cSpringer-Verlag France 311 $a1269-3286 531 $aHEMATOL CELL THER 531 $aHEMATOLOGY & CELL THERAPY 606 $aHematology$vPeriodicals 606 $aBone marrow$xTransplantation$vPeriodicals 606 $aBlood products$vPeriodicals 606 $aBlood$xDiseases$vPeriodicals 606 $aHématologie$vPériodiques 606 $aMoelle osseuse$xGreffe$vPériodiques 606 $aProduits sanguins$vPériodiques 606 $aSang$xMaladies$vPériodiques 606 $aBlood$xDiseases$2fast$3(OCoLC)fst00834579 606 $aBlood products$2fast$3(OCoLC)fst00834806 606 $aBone marrow$xTransplantation$2fast$3(OCoLC)fst00835952 606 $aHematology$2fast$3(OCoLC)fst00954904 606 $aHämatologie$2gnd 606 $aFrischzellentherapie$2gnd 606 $aKnochenmarktransplantation$2gnd 606 $aZeitschrift$2gnd 606 $aOnline-Ressource$2gnd 606 $aBlutkrankheit$2gnd 606 $aBlood Component Transfusion 606 $aBone Marrow Transplantation 606 $aHematology 606 $aHematologic Diseases 608 $aPeriodicals.$2fast 608 $aZeitschrift$2swd 608 $aOnline-Publikation$2swd 608 $aFulltext. 608 $aInternet Resources. 608 $aPeriodicals. 608 $aPeriodicals.$2lcgft 615 0$aHematology 615 0$aBone marrow$xTransplantation 615 0$aBlood products 615 0$aBlood$xDiseases 615 6$aHématologie 615 6$aMoelle osseuse$xGreffe 615 6$aProduits sanguins 615 6$aSang$xMaladies 615 7$aBlood$xDiseases. 615 7$aBlood products. 615 7$aBone marrow$xTransplantation. 615 7$aHematology. 615 7$aHämatologie 615 7$aFrischzellentherapie 615 7$aKnochenmarktransplantation 615 7$aZeitschrift 615 7$aOnline-Ressource 615 7$aBlutkrankheit 615 12$aBlood Component Transfusion. 615 12$aBone Marrow Transplantation. 615 12$aHematology. 615 22$aHematologic Diseases. 712 02$aSociété française de greffe de moelle, 712 02$aSociété française d'hématologie, 906 $aJOURNAL 912 $a996204134003316 996 $aHematology and cell therapy$92493630 997 $aUNISA LEADER 05785nam 22007455 450 001 9911015970603321 005 20250718130302.0 010 $a3-031-93425-3 024 7 $a10.1007/978-3-031-93425-4 035 $a(MiAaPQ)EBC32226432 035 $a(Au-PeEL)EBL32226432 035 $a(CKB)39672014000041 035 $a(DE-He213)978-3-031-93425-4 035 $a(EXLCZ)9939672014000041 100 $a20250718d2025 u| 0 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aCell Membrane Engineering for Advancing Cell-Based and Nanotechnology-Based Therapies /$fedited by Zahid Hussain, Renjun Pei 205 $a1st ed. 2025. 210 1$aCham :$cSpringer Nature Switzerland :$cImprint: Springer,$d2025. 215 $a1 online resource (664 pages) 225 1 $aBiomaterials, Bioengineering and Sustainability,$x2731-7528 ;$v6 311 08$a3-031-93424-5 327 $a -- Biological Membrane Engineering for Unlocking Therapeutic Potential of Membrane-Based Platforms. -- Engineering Cell Membrane-Derived Nanovesicles for Advanced Biomedical Applications. -- Engineered Bacterial Membrane Vesicles for Advanced Biomedical Applications. -- Hybrid Cell Membrane Engineered Platform for Theranostic Application. -- Functional Biomaterials used for Cell Membrane Engineering and their Functional Aspects. -- Genetically Mediated Cell Membrane Engineering Strategies and Their Scope in Biomedical Applications. -- Biomaterial-Based Cell Membrane Engineering Strategies and Their Scope in Biomedical Applications. -- Harnessing Cell Surface Engineering for Tissue Engineering and Regenerative Medicine. -- Harnessing Biomaterial-Mediated Single-Cell Nanoencapsulation for Enhanced Cellular Therapies. -- Harnessing Engineered Probiotics for Gastrointestinal Diseases Therapy. -- Cell Membrane Engineering for Advancing Cancer Immunotherapy. -- Cellular Membrane Engineering Platform for Capturing and Neutralizing Circulating Tumor Cells. -- Engineered Mammalian Cell and Bacterial Membrane-Based Nanovaccines and Nanoplatforms for Cancer Therapy and Infectious Disease . -- Cell Membrane Engineering for Advancing Precision Drug Delivery for Cancer Therapy. -- Cell Membrane Engineering for Advancing Drug Delivery Against Infectious Diseases. -- Cell Membrane Engineering for Advanced Drug Delivery Against Neurodegenerative and Inflammatory Diseases. 330 $aThe battle against complex diseases and tissue defects drives innovation in treatment and medical research. The cell membrane plays a fundamental role in biological processes and serves as a promising platform for diagnostic and therapeutic advancements due to its diverse receptors and ligands. Recent advances in bioengineering, synthetic biology, and biomimetic nanotechnology have enabled the development of engineered cell membrane-based platforms, including surface-engineered cells, extracellular vesicles, bacterial membrane vesicles, membrane-coated nanoparticles, and hybrid nanomaterials, offering improved therapeutic and diagnostic potential over their natural counterparts. This book provides a comprehensive exploration of essential cell surfaceome components, detailing state-of-the-art surface engineering strategies and advancements in engineered cells and membrane-based therapeutic nanoplatforms. It examines the transformative applications of these platforms in immune engineering, gastrointestinal disease management, cancer therapy, tissue engineering, circulating tumor cell capture, theranostics, and the treatment of neurodegenerative, inflammatory, and infectious diseases. Significant topics, many at the forefront of scientific research, are examined in depth, allowing academics, clinicians, and biomedical researchers to understand the latest advancements in cell membrane engineering and address unmet clinical needs. Furthermore, this interdisciplinary book is highly relevant to modern healthcare and provides instructional content for graduate students in chemical biology, pharmacology, biomaterials science, biomedical engineering, immune engineering, nanobiotechnology, regenerative medicine, and translational medicine. This book brings together pioneering research to inspire a broad scientific audience and drive innovation in disease monitoring, precision treatment, and biomedical applications. 410 0$aBiomaterials, Bioengineering and Sustainability,$x2731-7528 ;$v6 606 $aBiomaterials 606 $aCells 606 $aBiomedical engineering 606 $aMembranes (Biology) 606 $aNanotechnology 606 $aMedicine$xResearch 606 $aBiology$xResearch 606 $aBiomaterials-Cells 606 $aBiomedical Engineering and Bioengineering 606 $aBiological Membranes 606 $aNanotechnology 606 $aBiomedical Materials 606 $aBiomedical Research 615 0$aBiomaterials. 615 0$aCells. 615 0$aBiomedical engineering. 615 0$aMembranes (Biology) 615 0$aNanotechnology. 615 0$aMedicine$xResearch. 615 0$aBiology$xResearch. 615 14$aBiomaterials-Cells. 615 24$aBiomedical Engineering and Bioengineering. 615 24$aBiological Membranes. 615 24$aNanotechnology. 615 24$aBiomedical Materials. 615 24$aBiomedical Research. 676 $a620.19 700 $aHussain$b Zahid$01834525 701 $aPei$b Renjun$01834526 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9911015970603321 996 $aCell Membrane Engineering for Advancing Cell-Based and Nanotechnology-Based Therapies$94410016 997 $aUNINA